February 09, 2026 a 06:00 pm
MRK: Fundamental Ratio Analysis - Merck & Co., Inc.
Merck & Co., Inc., a leading player in the healthcare sector, operates globally through its Pharmaceutical and Animal Health segments. The stock appears stable, with a balanced performance across various metrics, making it a compelling option for investors seeking exposure to the healthcare industry.
Fundamental Rating
The fundamental data reflects a solid overall score, notwithstanding select areas needing improvement.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 1 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 2 |
Historical Rating
The historical data provides insight into the company's rating trends and its consistent performance over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-09 | 3 | 4 | 5 | 1 | 1 | 3 | 2 |
| Previous | 0 | 4 | 5 | 1 | 1 | 3 | 2 |
Analyst Price Targets
Analyst price targets indicate a positive stock outlook with potential price appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $136 | $90 | $122 | $119.91 |
Analyst Sentiment
The sentiment from analysts remains optimistic, with a consensus rating of 'Buy'.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 24 | |
| Hold | 11 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Merck & Co., Inc. demonstrates robust financial fundamentals and strong analyst support, positioning it as a solid investment in the healthcare space. Although certain areas show scope for improvement, the overall outlook remains positive. Analysts recommend a 'Buy', reflecting confidence in the company's growth prospects. Potential investors should consider the inherent risks associated with market volatility but can be encouraged by Merck's resilient historical performance and solid market presence.